Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.

Kramer BS, Hagerty KL, Justman S, Somerfield MR, Albertsen PC, Blot WJ, Ballentine Carter H, Costantino JP, Epstein JI, Godley PA, Harris RP, Wilt TJ, Wittes J, Zon R, Schellhammer P, American Society of Clinical Oncology Health Services Committee, American Urological Association Practice Guidelines Committee
J Clin Oncol. 2009 27 (9): 1502-16

PMID: 19252137 · PMCID: PMC2668556 · DOI:10.1200/JCO.2008.16.9599

MeSH Terms (5)

5-alpha Reductase Inhibitors Enzyme Inhibitors Humans Male Prostatic Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities: